{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T01:20:28Z","timestamp":1783128028624,"version":"3.54.6"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:00:00Z","timestamp":1778889600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-113A1-CACO-13242402"],"award-info":[{"award-number":["NHRI-113A1-CACO-13242402"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004737","name":"National Health Research Institutes","doi-asserted-by":"publisher","award":["NHRI-114A1-CACO-13252502"],"award-info":[{"award-number":["NHRI-114A1-CACO-13252502"]}],"id":[{"id":"10.13039\/501100004737","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022290","name":"Office of Research and Development, Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004700","name":"Taipei Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["NSTC 113-2320-B-110-007-MY3"],"award-info":[{"award-number":["NSTC 113-2320-B-110-007-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["113-2320-B-110-005-MY3"],"award-info":[{"award-number":["113-2320-B-110-005-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejps.2026.107558","type":"journal-article","created":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T15:29:51Z","timestamp":1778945391000},"page":"107558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A phenothiazine analog, PTF, suppresses breast cancer growth by inhibiting YAP signaling"],"prefix":"10.1016","volume":"222","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4934-9126","authenticated-orcid":false,"given":"Jing-Ru","family":"Weng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Yuan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Lan","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Hsien","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih-Jiuan","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2026.107558_bib0001","doi-asserted-by":"crossref","DOI":"10.1177\/17588359251358947","article-title":"Capivasertib\/Fulvestrant in patients with HR+, HER2-low or HER2-negative locally advanced or metastatic breast cancer","volume":"17","author":"Aboud","year":"2025","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.ejps.2026.107558_bib0002","doi-asserted-by":"crossref","first-page":"16084","DOI":"10.18632\/oncotarget.14306","article-title":"The Hippo signaling pathway provides novel anti-cancer drug targets","volume":"8","author":"Bae","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejps.2026.107558_bib0003","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1158\/2159-8290.CD-13-0286","article-title":"Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targets","volume":"4","author":"Balko","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejps.2026.107558_bib0004","doi-asserted-by":"crossref","DOI":"10.1080\/08941939.2023.2266732","article-title":"Verteporfin suppresses YAP-induced glycolysis in breast cancer cells","volume":"36","author":"Chen","year":"2023","journal-title":"J. Invest. Surg."},{"key":"10.1016\/j.ejps.2026.107558_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s40364-022-00365-5","article-title":"The biology of YAP in programmed cell death","volume":"10","author":"Cheng","year":"2022","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ejps.2026.107558_bib0006","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1002\/tox.23128","article-title":"A macrolide from Streptomyces sp. modulates apoptosis and autophagy through Mcl-1 downregulation in human breast cancer cells","volume":"36","author":"Chiu","year":"2021","journal-title":"Environ. Toxicol."},{"key":"10.1016\/j.ejps.2026.107558_bib0007","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3390\/life11040365","article-title":"Inhibition of autophagy enhances the antitumor effect of thioridazine in acute lymphoblastic leukemia cells","volume":"11","author":"Colturato-Kido","year":"2021","journal-title":"Life"},{"key":"10.1016\/j.ejps.2026.107558_bib0008","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s12964-024-01647-1","article-title":"Bcl-2 dependent modulation of Hippo pathway in cancer cells","volume":"22","author":"D'Aguanno","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.ejps.2026.107558_bib0009","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.currproblcancer.2018.12.005","article-title":"Yes-associated protein expression in paired primary and local recurrent breast cancer and its clinical significance","volume":"43","author":"Ding","year":"2019","journal-title":"Curr. Probl. Cancer"},{"key":"10.1016\/j.ejps.2026.107558_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.116850","article-title":"Strategic advancements in targeting the PI3K\/AKT\/mTOR pathway for breast cancer therapy","volume":"236","author":"Garg","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107558_bib0011","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/2211-5463.12597","article-title":"YAP1 overexpression is associated with poor prognosis of breast cancer patients and induces breast cancer cell growth by inhibiting PTEN","volume":"9","author":"Guo","year":"2019","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.ejps.2026.107558_bib0012","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/nrc3458","article-title":"The Hippo pathway and human cancer","volume":"13","author":"Harvey","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ejps.2026.107558_bib0013","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12943-024-02172-y","article-title":"Mechanisms and cross-talk of regulated cell death and their epigenetic modifications in tumor progression","volume":"23","author":"He","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ejps.2026.107558_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114403","article-title":"Chlorpromazine, an antipsychotic agent, induces G2\/M phase arrest and apoptosis via regulation of the PI3K\/AKT\/mTOR-mediated autophagy pathways in human oral cancer","volume":"184","author":"Jhou","year":"2021","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107558_bib0015","article-title":"PI3K\/AKT\/mTOR axis in cancer: from pathogenesis to treatment","volume":"6","author":"Jiang","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.ejps.2026.107558_bib0016","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1620\/tjem.2022.J044","article-title":"Trifluoperazine synergistically potentiates bortezomib-induced anti-cancer effect in multiple myeloma via inhibiting P38 MAPK\/NUPR1","volume":"257","author":"Jing","year":"2022","journal-title":"Tohoku J. Exp. Med."},{"issue":"Pt 17","key":"10.1016\/j.ejps.2026.107558_bib0017","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1242\/jcs.113.17.2941","article-title":"Effector caspases are dispensable for the early nuclear morphological changes during chemical-induced apoptosis","volume":"113","author":"Johnson","year":"2000","journal-title":"J. Cell. Sci."},{"key":"10.1016\/j.ejps.2026.107558_bib0018","first-page":"3224","article-title":"Yes-associated protein (YAP) is differentially expressed in tumor and stroma according to the molecular subtype of breast cancer","volume":"7","author":"Kim","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.ejps.2026.107558_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115337","article-title":"Phenothiazines as anti-cancer agents: SAR overview and synthetic strategies","volume":"254","author":"Kumar","year":"2023","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2026.107558_bib0020","first-page":"80","article-title":"[Thioridazine sensitizes apoptotic effect of TRAIL in human lung cancer PC9 cells through ER stress mediated up-regulation of DR5]","volume":"20","author":"Li","year":"2017","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"10.1016\/j.ejps.2026.107558_bib0021","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2019.108888","article-title":"AMPK activation induced by promethazine increases NOXA expression and Beclin-1 phosphorylation and drives autophagy-associated apoptosis in chronic myeloid leukemia","volume":"315","author":"Medeiros","year":"2020","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejps.2026.107558_bib0022","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1158\/1078-0432.CCR-12-2991","article-title":"Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78","volume":"19","author":"Miao","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.ejps.2026.107558_bib0023","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1200\/JCO.19.00647","article-title":"Randomized trial of standard adjuvant chemotherapy regimens versus Capecitabine in older women with early breast cancer: 10-year update of the CALGB 49907 trial","volume":"37","author":"Muss","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ejps.2026.107558_bib0024","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s10495-020-01594-5","article-title":"Exploitation of a novel phenothiazine derivative for its anti-cancer activities in malignant glioblastoma","volume":"25","author":"Omoruyi","year":"2020","journal-title":"Apoptosis"},{"key":"10.1016\/j.ejps.2026.107558_bib0025","doi-asserted-by":"crossref","first-page":"3179","DOI":"10.1016\/j.ejmech.2011.05.013","article-title":"Recent progress in biological activities of synthesized phenothiazines","volume":"46","author":"Pluta","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejps.2026.107558_bib0026","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/s41416-025-02992-9","article-title":"Repurposing chlorpromazine for the treatment of triple-negative breast cancer growth and metastasis based on modulation of mitochondria-mediated apoptosis and autophagy\/mitophagy","volume":"132","author":"Pu","year":"2025","journal-title":"Br. J. Cancer."},{"key":"10.1016\/j.ejps.2026.107558_bib0027","doi-asserted-by":"crossref","DOI":"10.1002\/cai2.70016","article-title":"Global, regional, and national burden of breast cancer in adolescents and young adults aged 15\u201339 years from 1990 to 2021 based on the Global Burden of Disease Study 2021","volume":"4","author":"Qu","year":"2025","journal-title":"Cancer Innov."},{"key":"10.1016\/j.ejps.2026.107558_bib0028","doi-asserted-by":"crossref","first-page":"4130","DOI":"10.1038\/onc.2014.343","article-title":"ER\u03b2 decreases breast cancer cell survival by regulating the IRE1\/XBP-1 pathway","volume":"34","author":"Rajapaksa","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.ejps.2026.107558_bib0029","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.3390\/cancers12092438","article-title":"Interaction of the Hippo pathway and phosphatases in tumorigenesis","volume":"12","author":"Sarmasti Emami","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejps.2026.107558_bib0030","first-page":"10","article-title":"Cancer statistics, 2025","volume":"75","author":"Siegel","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.ejps.2026.107558_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2025.111582","article-title":"Ilimaquinone induces apoptosis in gastric cancer cells by inhibiting the signal transducer and activator of the transcription 3 pathway","volume":"417","author":"Su","year":"2025","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejps.2026.107558_bib0032","doi-asserted-by":"crossref","first-page":"6090","DOI":"10.7150\/ijbs.99859","article-title":"Repurposing of the antipsychotic trifluoperazine induces SLC7A11\/GPX4- mediated ferroptosis of oral cancer via the ROS\/autophagy pathway","volume":"20","author":"Tsai","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejps.2026.107558_bib0033","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.12659\/MSM.902522","article-title":"Trifluoperazine inhibits mesangial cell proliferation by arresting cell cycle-dependent mechanisms","volume":"23","author":"Wang","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.ejps.2026.107558_bib0034","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2022.101549","article-title":"Thioridazine combined with carboplatin results in synergistic inhibition of triple negative breast cancer by targeting cancer stem cells","volume":"26","author":"Wang","year":"2022","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.ejps.2026.107558_bib0035","article-title":"Pharmacological exploitation of the phenothiazine antipsychotics to develop novel antitumor agents-A drug repurposing strategy","volume":"6","author":"Wu","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejps.2026.107558_bib0036","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s00280-021-04386-z","article-title":"Repurposed antipsychotic chlorpromazine inhibits colorectal cancer and pulmonary metastasis by inducing G2\/M cell cycle arrest, apoptosis, and autophagy","volume":"89","author":"Xu","year":"2022","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107558_bib0037","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/5942379","article-title":"YAP overexpression in breast cancer cells promotes angiogenesis through activating YAP signaling in vascular endothelial cells","volume":"2022","author":"Yan","year":"2022","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.ejps.2026.107558_bib0038","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.cbi.2019.01.033","article-title":"The antipsychotic chlorpromazine suppresses YAP signaling, stemness properties, and drug resistance in breast cancer cells","volume":"302","author":"Yang","year":"2019","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejps.2026.107558_bib0039","doi-asserted-by":"crossref","first-page":"5974","DOI":"10.3748\/wjg.v29.i45.5974","article-title":"Thioridazine reverses trastuzumab resistance in gastric cancer by inhibiting S-phase kinase associated protein 2-mediated aerobic glycolysis","volume":"29","author":"Yang","year":"2023","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.ejps.2026.107558_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.taap.2024.117080","article-title":"Trifluoperazine exerts anti-osteosarcoma effect by inducing mitochondria-dependent apoptosis via AKT\/TXNIP signaling pathway","volume":"492","author":"Zeng","year":"2024","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.ejps.2026.107558_bib0041","article-title":"Endoplasmic reticulum stress in cancer","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm (2020)"},{"key":"10.1016\/j.ejps.2026.107558_bib0042","doi-asserted-by":"crossref","DOI":"10.5812\/ijpr-157923","article-title":"Therapeutic mechanisms of phenothiazine drugs: a mini-review of advances in cancer treatment and antibiotic resistance","volume":"24","author":"Zou","year":"2025","journal-title":"Iran J. Pharm. Res."},{"key":"10.1016\/j.ejps.2026.107558_bib0043","doi-asserted-by":"crossref","first-page":"888","DOI":"10.3390\/ph16060888","article-title":"Phenothiazine- and carbazole-cyanochalcones as dual inhibitors of tubulin polymerization and Human farnesyltransferase","volume":"16","author":"Zuba\u0219","year":"2023","journal-title":"Pharmaceuticals (Basel)"}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001326?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098726001326?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:57:06Z","timestamp":1783126626000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098726001326"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"alternative-id":["S0928098726001326"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107558","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A phenothiazine analog, PTF, suppresses breast cancer growth by inhibiting YAP signaling","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2026.107558","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107558"}}